Adding Bristol-Myers Squibb/AbbVie's Empliciti to Revlimid, developed by BMS' recently acquired Celgene unit, does not improve survival in untreated multiple myeloma, a study has shown. BMS announced ...
Abstract: In this article, a short fault diagnosis scheme for the power converter of switched reluctance motor drives system is proposed. To extract the current waveform and the short-circuit fault ...
Abstract: Internal short-circuit (ISC) faults represent a significant safety hazard for lithium-ion batteries (LIBs), potentially leading to thermal runaway and catastrophic safety incidents.